期刊文献+

止消保肾汤对早期糖尿病肾病NO及SOD的影响 被引量:4

Influence of Zhixiaobaoshen Decoction on nitric oxide and superoxide dismutase in patients with early diabetic nephropathy
原文传递
导出
摘要 目的观察止消保肾汤对早期糖尿病肾病一氧化氮(NO)和超氧化物歧化酶(SOD)的影响。方法将入选的68例患者随机分为对照组和治疗组各34例,对照组使用洛汀新治疗,治疗组使用止消保肾汤治疗。观察治疗前后症状积分变化,测定空腹血糖(FPS)、尿微量白蛋白排泄率(UAER)、血清NO水平及SOD活性。结果治疗8周后,两组均能明显降低FPS、UAER及NO,升高SOD活性(P<0.01);对照组症状积分改善不明显(P>0.05),治疗组不仅能明显改善症状积分(P<0.01),而且在降低UAER及NO水平,升高SOD活性方面均明显优于对照组(P<0.05)。结论止消保肾汤能降低早期DN患者的症状积分及UAER,可能与降低NO水平、升高SOD活性有关。 Objective To observe the influence of Zhixiaobaoshen Decoction on nitric oxide (NO) and superoxide dismutase (SOD) in patients with early diabetic nephropathy(DN). Methods Sixty-eight patients selected were randomly divided into the control group(n =34) and the treatment group(n =34). The control group was treated with Lotensin and the treatment group was treated with Zhixiaobaoshen Decoction. Changes of symptoms, fasting plasma sugar (FPS), urine albumin excretion ratio (UAER), NO level and SOD activity in serum were observed. Results After 8 weeks treatsment, FPS, UAER and the NO level were obviously reduced and SOD activity was obviously elevated in both groups (P 〈 0. 01 ), but the treatment group was better than the control group. The improvement of patients'symptoms was obvious in the treatment group(P 〈 0. 05), and was not obvious in the control group(P 〉0. 05). Conclusion Zhixiaobaoshen DeCoction can improve the symptoms and reduce UAER of patients with early DN, which is possibly related to reducing the NO level and elevating the SOD activity.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2007年第3期210-212,共3页 Journal of Beijing University of Traditional Chinese Medicine
基金 广西省卫生厅重点课题(No.200218)
关键词 止消保肾汤 早期糖尿病肾病 一氧化氮 超氧化物歧化酶 尿微量白蛋白 Zhixiaobaoshen Decoction early diabetic nephropathy nitric oxide superoxide dismutase urine microalbumin
  • 相关文献

参考文献8

二级参考文献26

  • 1唐政,季大玺,黎磊石,福井光峰,富野康日已.依那普利治疗SHR糖尿病大鼠对肾小球抗氧化酶及肾功能的影响[J].中华内分泌代谢杂志,1998,14(2):119-122. 被引量:9
  • 2曲晓璐(导师陈大舜).[D].湖南中医学院,2002,R.587.1.
  • 3田雪飞(导师陈大舜).[D].湖南中医学院,2001,R587.1.
  • 4Lacourciere Y, Belanger A, Godin C, et al. Long - term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy[J]. Kidney Int,2000, 58(2) : 762 - 769.
  • 5Singh R, Alavi N, Singh AK, et al. Role of angiotensin Ⅱ in glucose- induced inhibition of mesartgial matrix degradation[J]. Diabetes, 1999, 48(10): 2066-2073.
  • 6Tolins JP, Shultz PJ, Raij L, et al. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabeticrats: role of NO[J]. Am J Physiol, 1993,265(6) :886 - 895.
  • 7Ito S, Arima S, Ren YL, et al. Endothelitun- derived relaxing factor/nitric oxide modulates angiotensin Ⅱ action in the isolated microperfused rabbit afferent but not efferent arteriole[J]. J Clin Invest, 1993,91(5) :2012 - 2019.
  • 8Kohan DE. Endothehns in the normal and diseased kidney[J]. Am J Kidney Dis, 1997,(29)1:2-26.
  • 9Sharma K, Ziyadeh FN. Perspective in diabetes: hyperglycemia and diabetic kidney disease. The case for tranfforming growth factoras a key mediator[J]. Diabetes, 1995,44(10): 1139-1145.
  • 10朴忠浩,中国糖尿病杂志,1996年,4期,31页

共引文献236

同被引文献92

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部